CUVL Clinuvel Pharmaceuticals Limite
$4.96▲ +0.40%
Healthcare
Other
Volume 5.2K
Avg Volume (10D) 6.3K
Key Metrics & Fundamentals
Market Cap
$250.42M
P/E Ratio
11.0
Div Yield
0.73%
52W Range
4.88 - 8.92
% vs 50 MA
-17.36%
% vs 200 MA
-27.63%
RSI-14
31.5
MACD Histogram
-0.0300
Beta (1Y vs SPY)
0.63
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
3 Australian Biotech Stocks To Own In October 2026
Simply Wall St. · Oct 24, 2026 9:12 AM ET
Vita Life Sciences And 2 Other Australian Biotech Stocks To Watch
Simply Wall St. · Oct 17, 2026 8:15 AM ET
Top 3 Australian Biotech Stocks To Watch In October 2026
Simply Wall St. · Oct 10, 2026 7:14 AM ET
3 Great Australian Biotech Stocks With P E Under 14
Simply Wall St. · Oct 2, 2026 10:12 AM ET
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion
GlobeNewswire · Aug 27, 2026 1:42 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.